(19)

(11)

EP 3 911 253 A1

(12)

(43) Date of publication: 24.11.2021 Bulletin 2021/47 (21) Application number: 20741592.8 (22) Date of filing: 06.01.2020

(51) International Patent Classification (IPC):  A61B 17/12(2006.01) A61F 2/82(2013.01) A61F 2/07(2013.01) A61F 2/88(2006.01) (52) Cooperative Patent Classification (CPC): A61B 2017/0053; B29D 23/18; A61B 17/12154; A61B 17/12172; A61B 2017/00893; A61B 2017/00942; A61B 17/1214; A61B 2017/00898; A61B 2090/0807; A61B 17/12177; A61B 2090/3966; A61F 2/88; A61B 17/1215; A61B 17/12118; A61B 2017/00526; A61B 2017/12054; A61F 2/82; A61F 2/07 (86) International application number: PCT/US2020/012361 (87) International publication number: WO 2020/150023 (23.07.2020 Gazette 2020/30)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 18.01.2019 US 201962794536 P (71) Applicant: Neurogami Medical, Inc. Mountain View, CA 94043 (US)	(72) Inventors: HEBERT, Stephen, J. San Francisco, CA 94123 (US) BOJANOWSKI, Bartosz San Francisco, CA 94107 (US) (74) Representative: Lees, Kate Jane  Kate Lees Consulting Ltd Office 5 Acorn Business Centre Roberts End, Hanley Swan Malvern, Worcestershire WR8 0DN Malvern, Worcestershire WR8 0DN (GB)